Diagnosis and management of acute movement disorders

@article{Dressler2005DiagnosisAM,
  title={Diagnosis and management of acute movement disorders},
  author={D. Dressler and R. Benecke},
  journal={Journal of Neurology},
  year={2005},
  volume={252},
  pages={1299-1306}
}
Most movement disorders, reflecting degenerative disorders, develop in a slowly progressive fashion. Some movement disorders, however, manifest with an acute onset. We wish to give an overview of the management and therapy of those acute-onset movement disorders.Drug–induced movement disorders are mainly caused by dopamine–receptor blockers (DRB) as used as antipsychotics (neuroleptics) and antiemetics. Acute dystonic reactions usually occur within the first four days of treatment. Typically… Expand
Acute and subacute drug-induced movement disorders.
  • P. Burkhard
  • Psychology, Medicine
  • Parkinsonism & related disorders
  • 2014
TLDR
The present review focuses on drug-induced movement disorders that typically develop as an acute (hours to days) or subacute (days to weeks) event, including acute dystonic reactions, akathisia, drug- induced parkinsonism, neuroleptic malignant syndrome, serotonin syndrome, parkinsonisthesis-hyperpyrexia syndrome, and movement disorders associated with the use of recreational drugs. Expand
Movement disorders caused by medical disease.
TLDR
The spectrum of medical diseases associated with Parkinsonism, nonparkinsonian tremor, dystonia, and chorea have a wide variety of etiologies, requiring a careful medical history in the evaluation of new-onset movement disorders. Expand
Tourette's syndrome.
TLDR
Tourette's syndrome can mimic many hyperkinetic disorders, making the diagnosis challenging at times, and Appropriate diagnosis and treatment can substantially improve quality of life and psychosocial functioning in affected children. Expand
Acute dystonic reaction associated with increase in trazodone dose: a case report -
TLDR
A patient who developed an acute dystonic reaction after taking 100 mg trazodone and his symptoms resolved after receiving intra muscular anticholinergic treatment is described. Expand
Chorea in children: etiology, diagnostic approach and management
TLDR
The main causes, diagnosis and management of chorea in children, including Sydenham chorea, are reviewed and other etiologies such as dyskinetic cerebral palsy, anti-NMDAR receptor encephalitis, other autoimmune conditions, or mutations in NKX2-1, ADCY-5, FOXG1, GNAO1, and SYT-1 should be considered. Expand
Episodic ataxia type 4
TLDR
Episodic ataxia type 1 (EA1) is a potassium channelopathy characterized by constant myokymia and dramatic episodes of spastic contractions of the skeletal muscles of the head, arms, and legs with loss of both motor coordination and balance. Expand
Childhood Dystonias
  • S. Tabbal
  • Medicine
  • Current Treatment Options in Neurology
  • 2015
TLDR
Delivering optimal DBS therapy to children with dystonia requires a multidisciplinary team of experienced pediatric neurosurgeons, neurologists, and nurses to select adequate candidates, perform this delicate stereotactic procedure, and optimize DBS delivery. Expand
Movement disorders at a university hospital emergency room
TLDR
It was showed that a large proportion of the movement disorders seen in the ER are drugrelated, and careful selection of drugs while prescribing would decrease movement disorder-related visits to the ER. Expand
Cranial movement disorders: clinical features, pathophysiology, differential diagnosis and treatment
TLDR
The clinical features, pathophysiologies and therapies of the main movement disorders that affect the face, jaw, tongue and palate are reviewed. Expand
EXTRAPYRAMIDAL SYNDROMES CAUSED BY ANTIPSYCHOTICS EKSTRAPIRAMIDALNI SINDROMI IZAZVANI ANTIPSIHOTICIMA
TLDR
This paper gives a brief sum- mary of the literature with the emphasis on epidemiology, eti- ology, diagnosis and differential diagnosis, as well as the treatment of extrapyramidal disorders induced by antipsy- chotics, including dystonia and akathisia. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 67 REFERENCES
Neuroleptic malignant syndrome
TLDR
Data drawn from clinical observations and basic studies support the primary role of an acute reduction in brain dopamine activity in the development of neuroleptic malignant syndrome. Expand
Progression of Symptoms in Neuroleptic Malignant Syndrome
TLDR
A preliminary review of the temporal sequence of the four predominant signs of the neuroleptic malignant syndrome as described in 340 clinical reports of NMS shows that of all order implications, 70.5% were consistent with the sequence of mentalstatus changes, rigidity, hyperthermia, and autonomic dysfunction. Expand
Movement Disorders: A Comprehensive Survey
Some of the most curious conditions seen by clinicians are the aberrations of movement that reflect dysfunction of the motor control circuits of the brain. The manifestations of these disor­ ders mayExpand
Acute dystonia induced by neuroleptic drugs
TLDR
In view of the close similarity between dystonia in man and other primates, studies on the mechanisms whereby neuroleptic drugs cause acute dystonic reactions in monkeys may give some clues to the pathogenesis of spontaneous dystonIA in man. Expand
Akathisia: a comprehensive review and treatment summary.
TLDR
There are now valid and reliable methods to assess akathisia using standardized scales; doing so helps track the progress of treatment interventions and an overall treatment algorithm incorporating knowledge to date is presented. Expand
The paroxysmal dyskinesias
TLDR
The clinical, pathophysiological and genetic features of some of the paroxysmal movement disorders are reviewed and it is suggested that this disorder may be a channelopathy. Expand
Clinical characteristics and predisposing factors in acute drug-induced akathisia.
TLDR
The most significant predisposing factors were the extrapyramidal side effects score and current neuroleptic dose and its rate of increment, with lesser contributions from serum iron status and medication type. Expand
A rationale for NMDA receptor antagonist therapy of the neuroleptic malignant syndrome.
TLDR
NMS may be considered an iatrogenic excitatory aminoacid syndrome which is amenable to NMDA receptor antagonist therapy and may reduce increased muscle tone and prevent rhabdomyolysis. Expand
Novel antipsychotics and acute dystonic reactions.
  • M. Raja, A. Azzoni
  • Medicine
  • The international journal of neuropsychopharmacology
  • 2001
TLDR
The growing use of atypical antipsychotics has led to a decrease of acute dystonic reactions (ADR), and temporal relationship suggested that typical neuroleptics had caused ADR. Expand
Acute dystonia due to clozapine.
TLDR
An unusual case of acute dystonia in a 50-year-old male schizophrenic patient with marked extrapyramidal side effects is reported, which may be considered more typical in a youtnger male patient, but several aspects are remarkable and atypical. Expand
...
1
2
3
4
5
...